4 Reasons Social Security Is In Trouble - Will You Be, Too?
Worst Things to Buy Before Your Kid Heads Back to School
Monkeys' Behavior Reveals Hidden Threat to Our Wealth
Can Apple Restore the Luster of the iPad?
Johnson & Johnson Launches Offer for Crucell
Giant drugmaker Johnson & Johnson has agreed to buy Dutch vaccine maker Crucell. The deal will give J&J a bigger piece of the vaccine market and better access to emerging markets.
Still in hot water over its "phantom recall" of a Motrin product, Johnson & Johnson looks to expand its share of the vaccine market with purchase of Dutch pharma company Crucell.
Novavax (NVAX) shares soared some 10 percent today after the small clinical-stage biotechnology company announced positive preclinical results for...